Baltic and Eurasia Masterclass in Clinical Oncology

 

Baltic and Eurasia Masterclass in Clinical Oncology
Avatar

The Role of Targeted and Chemotherapy in Metastatic NSCLC: TKIs in EGFRm, Mechanisms of Acquired Resistance, and New Treatment Options

By Baltic and Eurasia Masterclass in Clinical Oncology FEATURING Sergei Tjulandin
By Baltic and Eurasia Masterclass in Clinical Oncology FEATURING Sergei Tjulandin
0 views
August 23, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley
Lung
22:50
Baltic and Eurasia Masterclass in Clinical Oncology

Small Cell Lung Cancer: Disease Overview, Staging and Treatment Appr…

Feat. D. Jovanovic
29:12
Baltic and Eurasia Masterclass in Clinical Oncology

Principles of Immunotherapy in Advanced NSCLC: Efficacy, TMB and Com…

Feat. D. Jovanovic
26:42
Baltic and Eurasia Masterclass in Clinical Oncology

Immunotherapy in Advanced NSCLC: PD-L1 Treatment Modalities in Clini…

Feat. D. Jovanovic
28:27
Baltic and Eurasia Masterclass in Clinical Oncology

The Role of Targeted and Chemotherapy in Metastatic NSCLC: TKIs in E…

Feat. S. Tjulandin
25:48
Baltic and Eurasia Masterclass in Clinical Oncology

Radiotherapy in Lung Cancer: PET-CT, Concurrent vs. Sequential chemo…

Feat. P. Van Houtte